セルソースの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/01/10 | 827 | 853 | 820 | 830 | ±0 | ±0% | 73,600 |
| 2025/01/09 | 857 | 857 | 824 | 830 | -33 | -3.8% | 125,300 |
| 2025/01/08 | 841 | 885 | 833 | 863 | +37 | +4.5% | 210,700 |
| 2025/01/07 | 833 | 849 | 825 | 826 | +1 | +0.1% | 67,300 |
| 2025/01/06 | 842 | 851 | 825 | 825 | -7 | -0.8% | 67,600 |
| 2024/12/30 | 835 | 847 | 820 | 832 | -1 | -0.1% | 94,300 |
| 2024/12/27 | 808 | 849 | 803 | 833 | +25 | +3.1% | 95,700 |
| 2024/12/26 | 818 | 845 | 808 | 808 | -14 | -1.7% | 155,000 |
| 2024/12/25 | 804 | 828 | 804 | 822 | +16 | +2% | 143,400 |
| 2024/12/24 | 828 | 828 | 803 | 806 | -22 | -2.7% | 180,300 |
| 2024/12/23 | 843 | 862 | 828 | 828 | ±0 | ±0% | 129,900 |
| 2024/12/20 | 851 | 883 | 828 | 828 | -15 | -1.8% | 157,400 |
| 2024/12/19 | 860 | 860 | 835 | 843 | -18 | -2.1% | 113,000 |
| 2024/12/18 | 878 | 881 | 854 | 861 | -2 | -0.2% | 121,500 |
| 2024/12/17 | 908 | 910 | 827 | 863 | -40 | -4.4% | 421,000 |
| 2024/12/16 | 1,000 | 1,000 | 901 | 903 | -92 | -9.2% | 428,700 |
| 2024/12/13 | 999 | 1,010 | 983 | 995 | -57 | -5.4% | 432,400 |
| 2024/12/12 | 1,103 | 1,146 | 1,036 | 1,052 | +30 | +2.9% | 371,100 |
| 2024/12/11 | 1,030 | 1,039 | 1,018 | 1,022 | -2 | -0.2% | 51,700 |
| 2024/12/10 | 1,033 | 1,040 | 1,020 | 1,024 | -26 | -2.5% | 85,700 |
| 2024/12/09 | 1,027 | 1,066 | 1,027 | 1,050 | +32 | +3.1% | 108,900 |
| 2024/12/06 | 1,017 | 1,027 | 1,009 | 1,018 | -10 | -1% | 49,600 |
| 2024/12/05 | 1,013 | 1,037 | 1,013 | 1,028 | +3 | +0.3% | 87,500 |
| 2024/12/04 | 1,059 | 1,059 | 1,025 | 1,025 | -47 | -4.4% | 99,900 |
| 2024/12/03 | 1,081 | 1,082 | 1,054 | 1,072 | -13 | -1.2% | 82,400 |
| 2024/12/02 | 1,104 | 1,111 | 1,083 | 1,085 | -11 | -1% | 35,900 |
| 2024/11/29 | 1,094 | 1,105 | 1,078 | 1,096 | -2 | -0.2% | 49,300 |
| 2024/11/28 | 1,082 | 1,134 | 1,082 | 1,098 | +2 | +0.2% | 60,500 |
| 2024/11/27 | 1,128 | 1,128 | 1,082 | 1,096 | -42 | -3.7% | 93,600 |
| 2024/11/26 | 1,139 | 1,147 | 1,128 | 1,138 | -1 | -0.1% | 28,600 |
| 2024/11/25 | 1,135 | 1,157 | 1,119 | 1,139 | +22 | +2% | 77,900 |
| 2024/11/22 | 1,140 | 1,145 | 1,110 | 1,117 | -29 | -2.5% | 68,100 |
| 2024/11/21 | 1,143 | 1,160 | 1,142 | 1,146 | ±0 | ±0% | 43,800 |
| 2024/11/20 | 1,140 | 1,163 | 1,139 | 1,146 | +19 | +1.7% | 73,300 |
| 2024/11/19 | 1,105 | 1,147 | 1,105 | 1,127 | +20 | +1.8% | 59,900 |
| 2024/11/18 | 1,124 | 1,128 | 1,107 | 1,107 | -24 | -2.1% | 57,900 |
| 2024/11/15 | 1,140 | 1,150 | 1,130 | 1,131 | ±0 | ±0% | 39,200 |
| 2024/11/14 | 1,145 | 1,155 | 1,125 | 1,131 | -10 | -0.9% | 47,700 |
| 2024/11/13 | 1,162 | 1,173 | 1,141 | 1,141 | -21 | -1.8% | 48,300 |
| 2024/11/12 | 1,164 | 1,188 | 1,160 | 1,162 | -2 | -0.2% | 36,500 |
| 2024/11/11 | 1,163 | 1,178 | 1,150 | 1,164 | -10 | -0.9% | 48,100 |
| 2024/11/08 | 1,165 | 1,192 | 1,165 | 1,174 | +5 | +0.4% | 40,600 |
| 2024/11/07 | 1,190 | 1,233 | 1,165 | 1,169 | -22 | -1.8% | 106,700 |
| 2024/11/06 | 1,191 | 1,200 | 1,165 | 1,191 | +14 | +1.2% | 65,400 |
| 2024/11/05 | 1,189 | 1,199 | 1,164 | 1,177 | -11 | -0.9% | 52,100 |
| 2024/11/01 | 1,175 | 1,195 | 1,171 | 1,188 | +1 | +0.1% | 44,600 |
| 2024/10/31 | 1,176 | 1,198 | 1,172 | 1,187 | +5 | +0.4% | 42,600 |
| 2024/10/30 | 1,185 | 1,198 | 1,172 | 1,182 | -6 | -0.5% | 68,800 |
| 2024/10/29 | 1,174 | 1,192 | 1,173 | 1,188 | +14 | +1.2% | 40,000 |
| 2024/10/28 | 1,140 | 1,192 | 1,140 | 1,174 | +34 | +3% | 57,100 |
101～
150
件表示中 / 1371件
類似銘柄と比較する
現在ご覧いただいている「セルソース」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| セルソース | 69,800円 | - | - | 0.72% | 54.23倍 | 2.31倍 |
|
脂肪・血液由来の細胞加工受託など再生医療、変形性ひざ関節症向け軸に不妊治療関連も展開 |
| ラクオリア | 64,800円 | +25.1% | - | 0.00% | - | 2.86倍 |
|
ファイザー旧国内研究所が前身。導出消化器薬の海外売上が拡大、収益柱に。低分子創薬に強い |
| オンコリス | 62,700円 | +3771.0% | - | 0.00% | - | 5.68倍 |
|
腫瘍溶解ウイルス技術使うがん治療薬柱に感染症薬も開発。導出先が神経疾患薬を米国治験中 |
| キッズバイオ | 27,800円 | - | - | 0.00% | - | 9.90倍 |
|
北大発創薬ベンチャー。バイオ後続品を主力に、乳歯歯髄幹細胞（ＳＨＥＤ）用いた再生医療に力 |
| ステラファーマ | 38,800円 | +4.8% | - | 0.00% | - | 4.12倍 |
|
ステラケミファ系、持分会社に。がん放射線治療用ホウ素医薬品が柱。適応拡大・海外展開注力 |
市場注目の銘柄
チャート関連のコラム
